Since its founding in 1979, The Skin Cancer Foundation has set the standard for educating the public and the medical profession about skin cancer, its prevention by means of sun protection, the need for early detection, and prompt, effective treatment. It is the only international organization devoted solely to combating the world’s most common cancer, now occurring at epidemic levels.
In furthering this mission, The Skin Cancer Foundation partners with individuals, professionals, and corporations. We value our corporate partners and the role they play in our fight. At the same time, we recognize the importance of transparency to maintain the integrity of our organization and to ensure all of our constituents understand our financial and organizational stewardship. As a result, our organization has promulgated the following corporate engagement policy:
Corporate Engagement Philosophy
Subject to limitations provided herein, The Skin Cancer Foundation accepts funding from corporations for research, educational and community outreach programs, public policy, international programs, and general operations. We are committed to responsible engagement with corporations in keeping with our mission, and compliance with all rules and regulations to promote ethical and transparent business arrangements.
Selection of Corporate Partners
Corporate relationships must have a meaningful mission-related benefit to the general public or to particular constituencies of The Skin Cancer Foundation.
The Skin Cancer Foundation does not endorse any medical product or treatment, or any specific feature or attribute of any product sold by a corporate partner of the organization. Our Seal of Recommendation program is not an endorsement of any specific product. Instead, it recognizes sun protection products that meet our high standards for protection and have proven to be effective through laboratory testing. The criteria for the Seal of Recommendation are set by an volunteer committee of photobiologists, who also approve product applications for the program. Eligibility for the Seal program is a benefit of membership in our Corporate Council, which carries annual dues of $10,000. These dues are used to support The Skin Cancer Foundation’s mission, and have remained the same since the Seal program’s inception in 1981. They do not influence the approval or denial of any Seal application.
The Skin Cancer Foundation shall make best efforts to have a written agreement for each of its corporate engagements. Such agreement will detail the parameters of the use of the organization’s name and/or logo, and will require that the corporate partners comply with all applicable laws and regulations.
The Skin Cancer Foundation accepts funding from corporations to support educational content published on our website and in printed materials. Any such support is clearly stated. All content is reviewed by medical professionals independently, regardless of corporate funding.
Conflicts of Interest and Whistleblower Policy
The Board of Directors, Advisory Board, staff and certain volunteers and participants in our granting process are required to disclose potential conflicts of interest. Any potential conflicts are reviewed and addressed at least annually by the members of the Board of Directors.
Disclosure of Corporate Funding
The Skin Cancer Foundation discloses all corporate funding in its financial filings, which are available to the general public.